A PYMNTS Company

US: Noted antitrust attorney to lead nationwide class action suit over EpiPen pricing

By  |  April 27, 2017

A federal judge in Kansas has appointed Dallas lawyer Warren T. Burns and two other attorneys to lead a nationwide class action against Mylan NV and other defendants over pricing practices involving the EpiPen allergy treatment. Burns is a partner at Burns Charest, a litigation boutique with offices in Dallas and New Orleans.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Mylan, the US distributor of EpiPens, sparked outrage after raising the price of its life-saving product from $100 in 2008 to more than $600 by 2016. Congress and federal agencies have since opened investigations into EpiPen pricing.

    We’d love to be your preferred source for news.

    Please add us to your preferred sources list so our news, data and interviews show up in your feed. Thanks!

    Add as Preferred Source

    “This suit is about taking a stand for Americans who suffer life-threatening conditions,” Burns said. “We intend to send a message to Mylan and other companies that preying on the weak and the sick is no longer an accepted method of padding their bottom line.”

    Full Content: Yahoo

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.